Integrin α9 regulates smooth muscle cell phenotype switching and vascular remodeling

Excessive proliferation of vascular smooth muscle cells (SMCs) remains a significant cause of in-stent restenosis. Integrins, which are heterodimeric transmembrane receptors, play a crucial role in SMC biology by binding to the extracellular matrix protein with the actin cytoskeleton within the SMC....

Full description

Bibliographic Details
Main Authors: Manish Jain, Rishabh Dev, Prakash Doddapattar, Shigeyuki Kon, Nirav Dhanesha, Anil K. Chauhan
Format: Article
Language:English
Published: American Society for Clinical investigation 2021-05-01
Series:JCI Insight
Subjects:
Online Access:https://doi.org/10.1172/jci.insight.147134
_version_ 1811237526772383744
author Manish Jain
Rishabh Dev
Prakash Doddapattar
Shigeyuki Kon
Nirav Dhanesha
Anil K. Chauhan
author_facet Manish Jain
Rishabh Dev
Prakash Doddapattar
Shigeyuki Kon
Nirav Dhanesha
Anil K. Chauhan
author_sort Manish Jain
collection DOAJ
description Excessive proliferation of vascular smooth muscle cells (SMCs) remains a significant cause of in-stent restenosis. Integrins, which are heterodimeric transmembrane receptors, play a crucial role in SMC biology by binding to the extracellular matrix protein with the actin cytoskeleton within the SMC. Integrin α9 plays an important role in cell motility and autoimmune diseases; however, its role in SMC biology and remodeling remains unclear. Herein, we demonstrate that stimulated human coronary SMCs upregulate α9 expression. Targeting α9 in stimulated human coronary SMCs, using anti–integrin α9 antibody, suppresses synthetic phenotype and inhibits SMC proliferation and migration. To provide definitive evidence, we generated an SMC-specific α9-deficient mouse strain. Genetic ablation of α9 in SMCs suppressed synthetic phenotype and reduced proliferation and migration in vitro. Mechanistically, suppressed synthetic phenotype and reduced proliferation were associated with decreased focal adhesion kinase/steroid receptor coactivator signaling and downstream targets, including phosphorylated ERK, p38 MAPK, glycogen synthase kinase 3β, and nuclear β-catenin, with reduced transcriptional activation of β-catenin target genes. Following vascular injury, SMC-specific α9-deficient mice or wild-type mice treated with murine anti–integrin α9 antibody exhibited reduced injury-induced neointimal hyperplasia at day 28 by limiting SMC migration and proliferation. Our findings suggest that integrin α9 regulates SMC biology, suggesting its potential therapeutic application in vascular remodeling.
first_indexed 2024-04-12T12:25:06Z
format Article
id doaj.art-12712e6ca6e9479eada3274d2c28b3c0
institution Directory Open Access Journal
issn 2379-3708
language English
last_indexed 2024-04-12T12:25:06Z
publishDate 2021-05-01
publisher American Society for Clinical investigation
record_format Article
series JCI Insight
spelling doaj.art-12712e6ca6e9479eada3274d2c28b3c02022-12-22T03:33:10ZengAmerican Society for Clinical investigationJCI Insight2379-37082021-05-01610Integrin α9 regulates smooth muscle cell phenotype switching and vascular remodelingManish JainRishabh DevPrakash DoddapattarShigeyuki KonNirav DhaneshaAnil K. ChauhanExcessive proliferation of vascular smooth muscle cells (SMCs) remains a significant cause of in-stent restenosis. Integrins, which are heterodimeric transmembrane receptors, play a crucial role in SMC biology by binding to the extracellular matrix protein with the actin cytoskeleton within the SMC. Integrin α9 plays an important role in cell motility and autoimmune diseases; however, its role in SMC biology and remodeling remains unclear. Herein, we demonstrate that stimulated human coronary SMCs upregulate α9 expression. Targeting α9 in stimulated human coronary SMCs, using anti–integrin α9 antibody, suppresses synthetic phenotype and inhibits SMC proliferation and migration. To provide definitive evidence, we generated an SMC-specific α9-deficient mouse strain. Genetic ablation of α9 in SMCs suppressed synthetic phenotype and reduced proliferation and migration in vitro. Mechanistically, suppressed synthetic phenotype and reduced proliferation were associated with decreased focal adhesion kinase/steroid receptor coactivator signaling and downstream targets, including phosphorylated ERK, p38 MAPK, glycogen synthase kinase 3β, and nuclear β-catenin, with reduced transcriptional activation of β-catenin target genes. Following vascular injury, SMC-specific α9-deficient mice or wild-type mice treated with murine anti–integrin α9 antibody exhibited reduced injury-induced neointimal hyperplasia at day 28 by limiting SMC migration and proliferation. Our findings suggest that integrin α9 regulates SMC biology, suggesting its potential therapeutic application in vascular remodeling.https://doi.org/10.1172/jci.insight.147134Vascular biology
spellingShingle Manish Jain
Rishabh Dev
Prakash Doddapattar
Shigeyuki Kon
Nirav Dhanesha
Anil K. Chauhan
Integrin α9 regulates smooth muscle cell phenotype switching and vascular remodeling
JCI Insight
Vascular biology
title Integrin α9 regulates smooth muscle cell phenotype switching and vascular remodeling
title_full Integrin α9 regulates smooth muscle cell phenotype switching and vascular remodeling
title_fullStr Integrin α9 regulates smooth muscle cell phenotype switching and vascular remodeling
title_full_unstemmed Integrin α9 regulates smooth muscle cell phenotype switching and vascular remodeling
title_short Integrin α9 regulates smooth muscle cell phenotype switching and vascular remodeling
title_sort integrin α9 regulates smooth muscle cell phenotype switching and vascular remodeling
topic Vascular biology
url https://doi.org/10.1172/jci.insight.147134
work_keys_str_mv AT manishjain integrina9regulatessmoothmusclecellphenotypeswitchingandvascularremodeling
AT rishabhdev integrina9regulatessmoothmusclecellphenotypeswitchingandvascularremodeling
AT prakashdoddapattar integrina9regulatessmoothmusclecellphenotypeswitchingandvascularremodeling
AT shigeyukikon integrina9regulatessmoothmusclecellphenotypeswitchingandvascularremodeling
AT niravdhanesha integrina9regulatessmoothmusclecellphenotypeswitchingandvascularremodeling
AT anilkchauhan integrina9regulatessmoothmusclecellphenotypeswitchingandvascularremodeling